REAL

In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography

Trencsényi, György and Kis, Adrienn and Szabó, Judit P. and Ráti, Ágnes and Csige, Katalin and Fenyvesi, Éva and Szente, Lajos and Malanga, Milo and Méhes, Gábor and Emri, Miklós and Kertész, István and Vecsernyés, Miklós and Fenyvesi, Ferenc and Hajdu, István (2020) In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography. International Journal of Pharmaceutics, 576. pp. 1-10. ISSN 0378-5173

[img] Text
PET2_PGE2_Trencsenyi_IntJPharm2020.pdf
Restricted to Registered users only

Download (2MB)
Item Type: Article
Subjects: R Medicine / orvostudomány > RC Internal medicine / belgyógyászat > RC0254 Neoplasms. Tumors. Oncology (including Cancer) / daganatok, tumorok, onkológia
R Medicine / orvostudomány > RM Therapeutics. Pharmacology / terápia, gyógyszertan
Depositing User: Dr. Ferenc Fenyvesi
Date Deposited: 30 Oct 2020 16:29
Last Modified: 30 Oct 2020 16:29
URI: http://real.mtak.hu/id/eprint/116322

Actions (login required)

Edit Item Edit Item